Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000437589

Medchemexpress LLC Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride | 2376990-30-4 | 498.91 | 50 MG
SDP

Catalog No. 5000437589
Encompass_Preferred

Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride incorporates an E3 ligase ligand and a linker, and can be an immunomodulator for the treatment of cancer. PROTACs, which contain two different ligands connected by a linker (one for an E3 ubiquitin ligase and the other for the target protein), exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • Incorporates an E3 ligase ligand and a linker.
  • Can be an immunomodulator for the treatment of cancer.
  • Exploits the intracellular ubiquitin-proteasome system.
  • Selectively degrades target proteins.
  • For research use only.

Catalog No. 50-004-37589 Supplier Medchemexpress LLC Supplier No. HY112617B50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride incorporates an E3 ligase ligand and a linker, and can be an immunomodulator for the treatment of cancer. PROTACs, which contain two different ligands connected by a linker (one for an E3 ubiquitin ligase and the other for the target protein), exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.

  • Incorporates an E3 ligase ligand and a linker.
  • Can be an immunomodulator for the treatment of cancer.
  • Exploits the intracellular ubiquitin-proteasome system.
  • Selectively degrades target proteins.
  • For research use only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.